In a third AEGIS-Cell-SELEX experiment, cell engineering was used to place glypican 3 (GPC3), a possible marker for liver cancer diagnostic, on the surface of a murine cell line that does not express GPC3 (1MEA). This evidence concerns the gene GPC3 and liver cancer.